Quinine Sulfate Capsule
Product Images NDC 0093-3002

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Quinine Sulfate (NDC 0093-3002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Quinine Sulfate Structural Formula (Quinine Sulfate Capsule 091661 1)

FDA Label Image

Image (Quinine Sulfate Capsule 091661 2)

Image (Quinine Sulfate Capsule 091661 2)
Sulfate Capsules USP containing 30 capsules with 324mg quinine sulfate, USP per capsule. It is recommended to dispense the accompanying Medication Guide to each patient. The usual dosage is two capsules to be taken every eight hours for seven days. The medication should be stored at 20° to 25°C. It is manufactured in Canada by Teva and distributed by Teva Pharmaceuticals in the USA. Keep this and all medication out of the reach of children. However, the meaning of the last word "EXP" cannot be determined from this text, hence not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.